首页> 美国卫生研究院文献>Biochemical Journal >Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.
【2h】

Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.

机译:识别钙调蛋白结合区的单克隆抗体激活平滑肌肌球蛋白轻链激酶活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The regulatory domain of smooth muscle myosin light chain kinase (MLCK) was studied using monoclonal antibodies. Of the 22 monoclonal antibodies tested, a monoclonal antibody designated LKH-18 was found to activate MLCK in the absence of Ca2+/calmodulin. This activation was even greater when an Fab fragment of LKH-18 was used. Consequently, the actin-dependent smooth muscle myosin ATPase activity and the superprecipitation of actomyosin were significantly activated by MLCK plus LKH-18, even in the absence of Ca2+/calmodulin. The antibody-binding site was studied using proteolytic fragments and synthetic peptide analogues of MLCK. Immunoblot analysis revealed that LKH-18 reacted with the 66 kDa calmodulin-dependent active fragment but not with the 64 kDa inactive fragment or with the 61 kDa calmodulin-independent active fragment. Furthermore, LKH-18 reacted with MLCK-(796-815)-peptide but not with MLCK-(786-801)-peptide or with MLCK-(796-807)-peptide. Therefore the LKH-18-binding site was assigned to amino acid residues 808-815 of MLCK, which are thought to be a part of the calmodulin-binding site. The present results suggest that the binding of ligand to this region induces a conformation change in MLCK and that this abolishes the action of the inhibitory region which exists next to the N-terminal side of the calmodulin-binding site.
机译:使用单克隆抗体研究了平滑肌肌球蛋白轻链激酶(MLCK)的调节域。在测试的22种单克隆抗体中,发现在没有Ca2 + /钙调蛋白的情况下,命名为LKH-18的单克隆抗体可激活MLCK。当使用LKH-18的Fab片段时,该激活甚至更大。因此,即使没有Ca2 + /钙调蛋白,MLCK加LKH-18也会显着激活肌动蛋白依赖性平滑肌肌球蛋白ATPase活性和肌动球蛋白的过度沉淀。使用蛋白水解片段和MLCK的合成肽类似物研究了抗体结合位点。免疫印迹分析表明,LKH-18与66 kDa钙调蛋白依赖性活性片段反应,但不与64 kDa失活片段或61 kDa非钙调蛋白依赖性活性片段反应。此外,LKH-18与MLCK-(796-815)-肽反应但不与MLCK-(786-801)-肽或MLCK-(796-807)-肽反应。因此,将LKH-18结合位点分配给MLCK的氨基酸残基808-815,其被认为是钙调蛋白结合位点的一部分。目前的结果表明,配体与该区域的结合诱导了MLCK的构象变化,并且这消除了在钙调蛋白结合位点的N末端侧附近存在的抑制区域的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号